KRRO
Korro Bio, Inc.
$14.72
+0.23 (+1.59%)
At close · Jul 8
Market Cap
$212.30M
Shares
14,422,571
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$14.72
Open$14.29
Day$14.10–15.20
52W$5.20–55.89
Avg vol 30d243K
Short int1.3M · 9.1% float · 9.1d
Short vol79%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
+21%
above
RSI (14)
65
neutral
MACD trend
Positive
52-week position
19%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+39%
trailing
6-month return
+64%
trailing
YTD return
+84%
this year
Relative strength
+56%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $17 — 200d above 50d
Institutional flow
Distributing
2 of 99 funds reported for Jun 30 · net -28 sh shares
Insider flow
Distributing
Net -$416.1K over 90 days · 100% sells
Short interest
Rising
9.15% of float · ▲ +4.3% MoM · 9.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 2-yr high, broad support
Squeeze score
86
high risk · 0–100
Fundamentals
Revenue growth
+181%
Y/Y
EPS growth
−33%
Y/Y
Free cash flow
$-79.1M
Balance sheet
$21.8M
net cash
Quant / Vol
risk profile
Volatility
125%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
8.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 10, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
+21%
Bullish
RSI (14)
65
Neutral
MACD trend
Positive
Bullish
52-week position
19%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $12 › 200d $17 — 200d above 50d
Institutional flow
Distributing
2 of 99 funds reported for Jun 30 · net -28 sh shares
Insider flow
Distributing
Net -$416.1K over 90 days · 100% sells
Short interest
Rising
9.15% of float · ▲ +4.3% MoM · 9.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $5
Now $15 · 19%
52-wk high $56
vs 200-day avg -11%
vs 50-day avg +21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KRRO
this stock
Korro Bio, Inc.
|
$212.30M | +83.8% | +181.5% | — | 9.1% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KRRO | +11.7% | +39.0% | +63.7% | +11.7% | +83.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +11.9% | +38.2% | +56.3% | +11.9% | +74.5% |